NYTech
Companies
Companybiotech ai

OWKIN

Owkin is building the first BASI to unlock breakthroughs in therapies, diagnostics, and rejuvenation, while reshaping how humanity understands and engineers biology. Like other frontier AI companies, we believe the leap from narrow tools to true reasoning systems marks the start of a new era — where intelligence is not just assisting scientists but autonomously advancing discovery. Owkin’s moats are structural and compounding. We are creating the only large-scale reasoning model trained native[1][2]

Visit website Suggest an update
2016 Founded21 People on the graph

Overview

Owkin is a company operating in the New York artificial intelligence scene, categorized within biotech-AI[1]. The company focuses on building what it describes as the first BASI to unlock breakthroughs in therapies, diagnostics, and rejuvenation while reshaping how humanity understands and engineers biology[2]. According to the company's positioning, it represents a shift from narrow AI tools toward true reasoning systems that autonomously advance discovery rather than merely assisting scientists[2]. Owkin operates in the technology, information and internet sector[3] and employs 427 people[3].

Business address: 831 Broadway, New York, New York, 10003. [7]

Growth & traction

LinkedIn lists 427 people working at OWKIN. [4]

Leadership & org chart

Alumni

Focus

  • OWKIN describes itself as "We create the first closed-loop AI generative biology company to create the new standard of biology intelligence".[5]

Something wrong or missing? Send an update. Fixed within 24 hours.